| Year |
Citation |
Score |
| 2014 |
Choi J, Djebbar S, Fournier A, Labrie C. The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by endoplasmic reticulum stress. Cell Stress & Chaperones. 19: 439-46. PMID 24122553 DOI: 10.1007/S12192-013-0471-6 |
0.316 |
|
| 2013 |
Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. The Journal of Steroid Biochemistry and Molecular Biology. 138: 359-67. PMID 23954500 DOI: 10.1016/J.Jsbmb.2013.08.002 |
0.331 |
|
| 2012 |
Labrie F, Labrie C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric : the Journal of the International Menopause Society. 16: 205-13. PMID 23126249 DOI: 10.3109/13697137.2012.733983 |
0.346 |
|
| 2009 |
Léveillé N, Fournier A, Labrie C. Androgens down-regulate myosin light chain kinase in human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 114: 174-9. PMID 19429448 DOI: 10.1016/J.Jsbmb.2009.02.002 |
0.401 |
|
| 2009 |
Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause (New York, N.Y.). 16: 30-6. PMID 18820592 DOI: 10.1097/Gme.0B013E31817B6132 |
0.384 |
|
| 2008 |
Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 111: 178-94. PMID 18598765 DOI: 10.1016/J.Jsbmb.2008.06.003 |
0.382 |
|
| 2008 |
Labrie C, Lessard J, Ben Aicha S, Savard MP, Pelletier M, Fournier A, Lavergne E, Calvo E. Androgen-regulated transcription factor AIbZIP in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 108: 237-44. PMID 17933519 DOI: 10.1016/J.Jsbmb.2007.09.008 |
0.385 |
|
| 2008 |
Pelletier G, Labrie C, Martel C, Labrie F. Chronic administration of dehydroepiandrosterone (DHEA) to female monkey and rat has no effect on mammary gland histology Journal of Steroid Biochemistry and Molecular Biology. 108: 102-108. PMID 17933518 DOI: 10.1016/J.Jsbmb.2007.07.002 |
0.371 |
|
| 2007 |
Ben Aicha S, Lessard J, Pelletier M, Fournier A, Calvo E, Labrie C. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells. Physiological Genomics. 31: 295-305. PMID 17712038 DOI: 10.1152/Physiolgenomics.00097.2007 |
0.356 |
|
| 2007 |
Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 107: 57-69. PMID 17627814 DOI: 10.1016/J.Jsbmb.2007.02.007 |
0.321 |
|
| 2007 |
Lessard J, Aicha SB, Fournier A, Calvo E, Lavergne E, Pelletier M, Labrie C. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format. The Prostate. 67: 808-19. PMID 17373718 DOI: 10.1002/Pros.20559 |
0.382 |
|
| 2007 |
Levesque MH, El-Alfy M, Berger L, Labrie F, Labrie C. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases. Urology. 69: 196-201. PMID 17270658 DOI: 10.1016/J.Urology.2006.11.001 |
0.33 |
|
| 2006 |
Labrie F, Luu-The V, Martel C, Chernomoretz A, Calvo E, Morissette J, Labrie C. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG). The Journal of Steroid Biochemistry and Molecular Biology. 100: 52-8. PMID 16797178 DOI: 10.1016/J.Jsbmb.2006.03.006 |
0.385 |
|
| 2005 |
Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C. Is dehydroepiandrosterone a hormone? The Journal of Endocrinology. 187: 169-96. PMID 16293766 DOI: 10.1677/Joe.1.06264 |
0.421 |
|
| 2005 |
Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine Reviews. 26: 361-79. PMID 15867098 DOI: 10.1210/Er.2004-0017 |
0.386 |
|
| 2005 |
Labrie F, Luu-The V, Calvo E, Martel C, Cloutier J, Gauthier S, Belleau P, Morissette J, Lévesque MH, Labrie C. Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid. The Journal of Endocrinology. 184: 427-33. PMID 15684350 DOI: 10.1677/Joe.1.05997 |
0.34 |
|
| 2004 |
Labrie F, Cusan L, Gomez J, Luu-The V, Candas B, Bélanger A, Labrie C. Major impact of hormonal therapy in localized prostate cancer--death can already be an exception. The Journal of Steroid Biochemistry and Molecular Biology. 92: 327-44. PMID 15698538 DOI: 10.1016/J.Jsbmb.2004.10.011 |
0.379 |
|
| 2004 |
Bolduc C, Larose M, Yoshioka M, Ye P, Belleau P, Labrie C, Morissette J, Raymond V, Labrie F, St-Amand J. Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. Journal of Molecular Endocrinology. 33: 429-44. PMID 15525599 DOI: 10.1677/Jme.1.01503 |
0.333 |
|
| 2004 |
Leblanc M, Bélanger MC, Julien P, Tchernof A, Labrie C, Bélanger A, Labrie F. Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions. The Journal of Clinical Endocrinology and Metabolism. 89: 1849-57. PMID 15070955 DOI: 10.1210/Jc.2003-031233 |
0.646 |
|
| 2004 |
Labrie F, Champagne P, Labrie C, Roy J, Laverdière J, Provencher L, Potvin M, Drolet Y, Pollak M, Panasci L, L'Espérance B, Dufresne J, Latreille J, Robert J, Samson B, et al. Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer Journal of Clinical Oncology. 22: 864-871. PMID 14990642 DOI: 10.1200/Jco.2004.05.122 |
0.436 |
|
| 2003 |
Qi H, Grenier J, Fournier A, Labrie C. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Molecular and Cellular Endocrinology. 210: 51-62. PMID 14615060 DOI: 10.1016/J.Mce.2003.08.009 |
0.756 |
|
| 2003 |
Labrie F, Cusan L, Gomez JL, Candas B, Bélanger A, Luu-The V, Labrie C, Simard J. [From the gene to the clinic: prostate cancer death can now be an exception?]. Mã©Decine Sciences : M/S. 19: 910-9. PMID 14612999 DOI: 10.1051/Medsci/20031910910 |
0.378 |
|
| 2003 |
Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey. The Journal of Clinical Endocrinology and Metabolism. 88: 4293-302. PMID 12970301 DOI: 10.1210/Jc.2003-022012 |
0.679 |
|
| 2003 |
Labrie F, El-Alfy M, Berger L, Labrie C, Martel C, Bélanger A, Candas B, Pelletier G. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health? Endocrinology. 144: 4700-6. PMID 12960051 DOI: 10.1210/En.2003-0269 |
0.372 |
|
| 2003 |
Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews. 24: 152-82. PMID 12700178 DOI: 10.1210/Er.2001-0031 |
0.429 |
|
| 2003 |
Qi H, Fournier A, Grenier J, Fillion C, Labrie Y, Labrie C. Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells. Endocrinology. 144: 1742-52. PMID 12697679 DOI: 10.1210/En.2002-220984 |
0.748 |
|
| 2003 |
Pouliot F, Blais A, Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Research. 63: 277-81. PMID 12543773 |
0.555 |
|
| 2003 |
Gutman M, Couillard S, Labrie F, Candas B, Labrie C. Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice. International Journal of Cancer. 103: 268-76. PMID 12455043 DOI: 10.1002/Ijc.10803 |
0.782 |
|
| 2002 |
Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. The Journal of Steroid Biochemistry and Molecular Biology. 81: 159-64. PMID 12137806 DOI: 10.1016/S0960-0760(02)00059-6 |
0.674 |
|
| 2002 |
Blais A, Monté D, Pouliot F, Labrie C. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. The Journal of Biological Chemistry. 277: 31679-93. PMID 12077144 DOI: 10.1074/Jbc.M204554200 |
0.52 |
|
| 2002 |
Gutman M, Couillard S, Roy J, Labrie F, Candas B, Labrie C. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice. International Journal of Cancer. 99: 273-8. PMID 11979444 DOI: 10.1002/Ijc.10302 |
0.809 |
|
| 2002 |
Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Research. 62: 721-33. PMID 11830526 |
0.75 |
|
| 2002 |
Pouliot F, Labrie C. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. The Journal of Endocrinology. 172: 187-98. PMID 11786386 DOI: 10.1677/Joe.0.1720187 |
0.612 |
|
| 2002 |
Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M. Intracrinology and the skin. Hormone Research. 54: 218-29. PMID 11595810 DOI: 10.1159/000053264 |
0.332 |
|
| 2001 |
Lapointe J, Labrie C. Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation. Endocrinology. 142: 4331-4338. PMID 28204441 DOI: 10.1210/endo.142.10.8417 |
0.615 |
|
| 2001 |
Labrie F, Labrie C, Bélanger A, Simard J, Giguère V, Tremblay A, Tremblay G. EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium. The Journal of Steroid Biochemistry and Molecular Biology. 79: 213-225. PMID 11850228 DOI: 10.1016/S0960-0760(01)00139-X |
0.464 |
|
| 2001 |
Pelletier G, El-Alfy M, Labrie C, Martel C, Labrie F. Effect of Long-Term Treatment with the Antiestrogen EM-652.HCl on Pituitary Estrogen Receptor Alpha and Prolactin mRNA Expression in Intact, Ovariectomized and Gonadotropin- Releasing Hormone-Treated Female Rats Neuroendocrinology. 74: 367-374. PMID 11752893 DOI: 10.1159/000054703 |
0.329 |
|
| 2001 |
Lapointe J, Labrie C. Role of the cyclin-dependent kinase inhibitor p27kip1 in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation Endocrinology. 142: 4331-4338. PMID 11564693 DOI: 10.1210/Endo.142.10.8417 |
0.651 |
|
| 2001 |
Qi H, Labrie Y, Grenier J, Fournier A, Fillion C, Labrie C. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Molecular and Cellular Endocrinology. 182: 181-92. PMID 11514053 DOI: 10.1016/S0303-7207(01)00560-3 |
0.767 |
|
| 2001 |
Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Frontiers in Neuroendocrinology. 22: 185-212. PMID 11456468 DOI: 10.1006/Frne.2001.0216 |
0.492 |
|
| 2001 |
Labrie F, Labrie C, Bélanger A, Giguere V, Simard J, Mérand Y, Gauthier S, Luu-The V, Candas B, Martel C, Luo S. Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities. Advances in Protein Chemistry. 56: 293-368. PMID 11329857 DOI: 10.1016/S0065-3233(01)56009-X |
0.436 |
|
| 2001 |
Barbier O, Albert C, Martineau I, Vallée M, High K, Labrie F, Hum DW, Labrie C, Bélanger A. Glucuronidation of the nonsteroidal antiestrogen EM-652 (SCH 57068), by human and monkey steroid conjugating UDP-glucuronosyltransferase enzymes. Molecular Pharmacology. 59: 636-45. PMID 11179460 DOI: 10.1124/Mol.59.3.636 |
0.319 |
|
| 2001 |
Sourla A, Richard V, Labrie F, Labrie C. Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin. The Journal of Endocrinology. 166: 455-62. PMID 10927635 DOI: 10.1677/Joe.0.1660455 |
0.329 |
|
| 2000 |
Martel C, Picard S, Richard V, Bélanger A, Labrie C, Labrie F. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat. The Journal of Steroid Biochemistry and Molecular Biology. 74: 45-56. PMID 11074355 DOI: 10.1016/S0960-0760(00)00087-X |
0.319 |
|
| 2000 |
Picard F, Deshaies Y, Lalonde J, Samson P, Labrie C, Bélanger A, Labrie F, Richard D. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats International Journal of Obesity. 24: 830-840. PMID 10918529 DOI: 10.1038/Sj.Ijo.0801240 |
0.36 |
|
| 2000 |
Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G, Bélanger A. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. Journal of Molecular Endocrinology. 25: 1-16. PMID 10915214 DOI: 10.1677/Jme.0.0250001 |
0.305 |
|
| 2000 |
Pelletier C, Labrie C, Labrie F. Localization of oestrogen receptor α, oestrogen receptor β and androgen receptors in the rat reproductive organs Journal of Endocrinology. 165: 359-370. PMID 10810300 DOI: 10.1677/Joe.0.1650359 |
0.345 |
|
| 2000 |
Couillard S, Labrie C, Gauthier S, Merand Y, Singh SM, Candas B, Labrie F. Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice. International Journal of Cancer. 85: 424-9. PMID 10652436 DOI: 10.1002/(Sici)1097-0215(20000201)85:3<424::Aid-Ijc20>3.0.Co;2-S |
0.81 |
|
| 1999 |
Lapointe J, Fournier AA, Richard V, Labrie C. Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells* * This work was supported by a grant from the Canadian Breast Cancer Research Initiative (to C.L.), scholarships from the Fonds de la Recherche en Santé du Québec (to C.L. and J.L.). Additional financial support was provided by Endorecherche. Endocrinology. 140: 416-421. PMID 28200729 DOI: 10.1210/endo.140.1.6410 |
0.596 |
|
| 1999 |
Lapointe J, Labrie C. Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells1. Endocrinology. 140: 4486-4493. PMID 28200594 DOI: 10.1210/endo.140.10.7071 |
0.633 |
|
| 1999 |
Gutman M, Couillard S, Labrie F, Candas B, Labrie C. Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice. Cancer Research. 59: 5176-80. PMID 10537294 |
0.816 |
|
| 1999 |
Couillard S, Gutman M, Labrie F, Candas B, Labrie C. Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice. Cancer Research. 59: 4857-63. PMID 10519396 |
0.794 |
|
| 1999 |
Lapointe J, Labrie C. Identification and cloning of a novel androgen-Responsive gene, uridine diphosphoglucose dehydrogenase, in human breast cancer cells Endocrinology. 140: 4486-4493. PMID 10499502 DOI: 10.1210/Endo.140.10.7071 |
0.69 |
|
| 1999 |
Labrie F, Labrie C, Bélanger A, Simard J, Gauthier S, Luu-The V, Mérand Y, Giguere V, Candas B, Luo S, Martel C, Singh SM, Fournier M, Coquet A, Richard V, et al. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. The Journal of Steroid Biochemistry and Molecular Biology. 69: 51-84. PMID 10418981 DOI: 10.1016/S0960-0760(99)00065-5 |
0.484 |
|
| 1999 |
Pouliot F, Labrie C. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. International Journal of Cancer. 81: 98-103. PMID 10077159 DOI: 10.1002/(Sici)1097-0215(19990331)81:1<98::Aid-Ijc17>3.0.Co;2-9 |
0.573 |
|
| 1999 |
Lapointe J, Fournier A, Richard V, Labrie C. Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells Endocrinology. 140: 416-421. PMID 9886853 DOI: 10.1210/Endo.140.1.6410 |
0.699 |
|
| 1998 |
Martel CL, Labrie C, Be Langer A, Gauthier S, Me Rand Y, Li X, Provencher L, Candas B, Labrie F. Comparison of the Effects of the New Orally Active Antiestrogen EM-800 with ICI 182 780 and Toremifene on Estrogen-Sensitive Parameters in the Ovariectomized Mouse. Endocrinology. 139: 2486-2492. PMID 28200575 DOI: 10.1210/Endo.139.5.5968 |
0.361 |
|
| 1998 |
Tremblay A, Tremblay GB, Labrie C, Labrie F, Gigue Re V. EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors α and β. Endocrinology. 139: 111-118. PMID 28200444 DOI: 10.1210/Endo.139.1.5702 |
0.403 |
|
| 1998 |
Luo S, Labrie C, Bélanger A, Candas B, Labrie F. Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050). Breast Cancer Research and Treatment. 49: 1-11. PMID 9694606 DOI: 10.1023/A:1005928814521 |
0.349 |
|
| 1998 |
Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. The Journal of Endocrinology. 157: 433-42. PMID 9691976 DOI: 10.1677/Joe.0.1570433 |
0.311 |
|
| 1998 |
Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochemical and Biophysical Research Communications. 247: 146-53. PMID 9636670 DOI: 10.1006/Bbrc.1998.8497 |
0.586 |
|
| 1998 |
Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 63: 322-8. PMID 9618795 DOI: 10.1016/S0039-128X(98)00007-5 |
0.391 |
|
| 1998 |
Couillard S, Labrie C, Bélanger A, Candas B, Pouliot F, Labrie F. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts. Journal of the National Cancer Institute. 90: 772-8. PMID 9605648 DOI: 10.1093/Jnci/90.10.772 |
0.793 |
|
| 1998 |
Luo S, Sourla A, Labrie C, Gauthier S, Merand Y, Belanger A, Labrie F. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice. Endocrinology. 139: 2645-56. PMID 9564882 DOI: 10.1210/Endo.139.5.5994 |
0.398 |
|
| 1998 |
Luo S, Martel C, Chen C, Labrie C, Candas B, Singh SM, Labrie F. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. Urology. 50: 913-9. PMID 9426723 DOI: 10.1016/S0090-4295(97)00393-2 |
0.324 |
|
| 1998 |
Couillard S, Gutman M, Labrie C, Bélanger A, Candas B, Labrie F. Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice. Cancer Research. 58: 60-4. PMID 9426058 |
0.797 |
|
| 1997 |
Sourla A, Luo S, Labrie C, Be Langer A, Labrie F. Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800. Endocrinology. 138: 5605-5617. PMID 28200117 DOI: 10.1210/Endo.138.12.5560 |
0.406 |
|
| 1997 |
Luo S, Martel C, Gauthier S, Mérand Y, Bélanger A, Labrie C, Labrie F. Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice. International Journal of Cancer. 73: 735-9. PMID 9398055 DOI: 10.1002/(Sici)1097-0215(19971127)73:5<735::Aid-Ijc21>3.0.Co;2-3 |
0.51 |
|
| 1997 |
Luo S, Stojanovic M, Labrie C, Labrie F. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats. International Journal of Cancer. 73: 580-6. PMID 9389575 DOI: 10.1002/(Sici)1097-0215(19971114)73:4<580::Aid-Ijc20>3.0.Co;2-C |
0.414 |
|
| 1997 |
Luo S, Martel C, Sourla A, Gauthier S, Mérand Y, Belanger A, Labrie C, Labrie F. Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice. International Journal of Cancer. 73: 381-91. PMID 9359486 DOI: 10.1002/(Sici)1097-0215(19971104)73:3<381::Aid-Ijc13>3.0.Co;2-G |
0.379 |
|
| 1997 |
Simard J, Labrie C, Bélanger A, Gauthier S, Singh SM, Mérand Y, Labrie F. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. International Journal of Cancer. 73: 104-12. PMID 9334816 DOI: 10.1002/(Sici)1097-0215(19970926)73:1<104::Aid-Ijc16>3.0.Co;2-G |
0.451 |
|
| 1996 |
Labrie C, Flamand M, Bélanger A, Labrie F. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. Journal of Endocrinology. 150. DOI: 10.1677/Joe.0.150S107 |
0.371 |
|
| 1996 |
Couillard S, Labrie C, Gauthier S, Labrie F. F120 Inhibitory effect of a new non-steroidal pure antiestrogen (EM-800) in combination with DHEA on human ZR-75-1 breast tumors in nude mice Maturitas. 27: 80. DOI: 10.1016/S0378-5122(97)81081-X |
0.785 |
|
| 1995 |
Labrie F, Bélanger A, Simard J, Van Luu-The, Labrie C. DHEA and peripheral androgen and estrogen formation: intracinology. Annals of the New York Academy of Sciences. 774: 16-28. PMID 8597456 DOI: 10.1111/J.1749-6632.1995.Tb17369.X |
0.339 |
|
| 1993 |
Martel C, Trudel C, Couet J, Labrie C, Bélanger A, Labrie F. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA. Molecular and Cellular Endocrinology. 91: 43-9. PMID 8472853 DOI: 10.1016/0303-7207(93)90253-G |
0.377 |
|
| 1993 |
Labrie F, Belanger A, Simard J, Labrie C, Dupont A. Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy. Cancer. 71: 1059-67. PMID 8428328 DOI: 10.1002/1097-0142(19930201)71:3+<1059::Aid-Cncr2820711426>3.0.Co;2-6 |
0.381 |
|
| 1991 |
Poirier D, Labrie C, Mérand Y, Labrie F. Synthesis and biological activity of 17α-alkynylamide derivatives of estradiol Journal of Steroid Biochemistry and Molecular Biology. 38: 759-774. PMID 2064992 DOI: 10.1016/0960-0760(91)90090-R |
0.323 |
|
| 1991 |
Levesque C, Merand Y, Dufour JM, Labrie C, Labrie F. Synthesis and biological activity of new halo-steroidal antiestrogens. Journal of Medicinal Chemistry. 34: 1624-30. PMID 2033587 DOI: 10.1021/Jm00109A014 |
0.322 |
|
| 1991 |
Labrie C, Trudel C, Li S, Martel C, Couet J, Labrie F. COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE? Endocrinology. 128: 1673-1675. DOI: 10.1210/Endo-128-3-1673 |
0.362 |
|
| 1990 |
Labrie F, Poulin R, Simard J, Zhao HF, Labrie C, Dauvois S, Dumont M, Hatton AC, Poirier D, Mérand Y. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Annals of the New York Academy of Sciences. 595: 130-48. PMID 2142871 DOI: 10.1111/J.1749-6632.1990.Tb34288.X |
0.393 |
|
| 1990 |
Labrie C, Simard J, Zhao H, Bélanger A, Pelletier G, Labrie F. Stimulation of Androgen-Dependent Gene Expression by the Adrenal Precursors Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate Annals of the New York Academy of Sciences. 595: 395-398. DOI: 10.1111/J.1749-6632.1990.Tb34315.X |
0.326 |
|
| 1990 |
Labrie C, Simard J, Poulin M, Bélanger A, Pelletier G, Labrie F. Influence of the Duration of Androgen Deprivation on the Sensitivity of the Rat Ventral Prostate to Dehydroepiandrosterone and Androstenedione Annals of the New York Academy of Sciences. 595: 392-394. DOI: 10.1111/J.1749-6632.1990.Tb34314.X |
0.304 |
|
| 1989 |
Luu The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta. Molecular Endocrinology (Baltimore, Md.). 3: 1301-9. PMID 2779584 DOI: 10.1210/Mend-3-8-1301 |
0.304 |
|
| 1989 |
Simard J, Hatton AC, Labrie C, Dauvois S, Zhao HF, Haagensen DE, Labrie F. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 3: 694-702. PMID 2725533 DOI: 10.1210/Mend-3-4-694 |
0.357 |
|
| 1989 |
Poulin R, Simard J, Labrie C, Petitclerc L, Dumont M, Lagace L, Labrie F. Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology. 125: 392-9. PMID 2661209 DOI: 10.1210/Endo-125-1-392 |
0.377 |
|
| 1989 |
Labrie C, Simard J, Zhao HF, Belanger A, Pelletier G, Labrie F. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology. 124: 2745-54. PMID 2524377 DOI: 10.1210/Endo-124-6-2745 |
0.351 |
|
| 1988 |
Pelletier G, Labrie C, Simard J, Duval M, Martinoli MG, Zhao H, Labrie F. Effects of sex steroids on regulation of the levels of C1 peptide of rat prostatic steroid-binding protein mRNA evaluated by in-situ hybridization Journal of Molecular Endocrinology. 1: 213-223. PMID 2475128 DOI: 10.1677/Jme.0.0010213 |
0.329 |
|
| 1987 |
Labrie F, Dupont A, Bélanger A, Cusan L, Giguère M, Lacourcière Y, Luthy I, Bégin D, Labrie C, Simard J. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience. Cancer Metastasis Reviews. 6: 615-36. PMID 3327635 DOI: 10.1007/Bf00047470 |
0.425 |
|
| Show low-probability matches. |